Header Logo

Diego Cadavid

Concepts (299)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
22
2020
187
4.230
Why?
Borrelia
11
2011
25
2.950
Why?
Multiple Sclerosis, Chronic Progressive
6
2019
13
2.690
Why?
Relapsing Fever
8
2008
16
2.140
Why?
Optic Neuritis
5
2019
9
2.070
Why?
Brain
12
2013
1271
1.900
Why?
Antibodies, Monoclonal
5
2019
772
1.660
Why?
Interleukin-10
6
2011
132
1.660
Why?
Disability Evaluation
10
2019
181
1.650
Why?
Borrelia Infections
5
2010
11
1.640
Why?
Muscular Dystrophy, Facioscapulohumeral
4
2022
34
1.430
Why?
Multiple Sclerosis, Relapsing-Remitting
5
2019
31
1.390
Why?
Lyme Neuroborreliosis
5
2016
9
1.380
Why?
Immunologic Factors
7
2018
96
1.280
Why?
Borrelia burgdorferi
7
2016
66
1.250
Why?
Visual Acuity
3
2019
91
1.250
Why?
Lyme Disease
6
2016
96
1.190
Why?
Disease Progression
8
2022
777
1.140
Why?
Magnetic Resonance Imaging
15
2022
1571
1.120
Why?
Bacterial Outer Membrane Proteins
3
2010
133
1.030
Why?
Nerve Tissue Proteins
3
2019
402
1.010
Why?
Walking
6
2016
207
1.000
Why?
Chemokine CXCL13
5
2011
6
0.940
Why?
Spirochaetales
3
2010
4
0.830
Why?
Membrane Proteins
3
2019
774
0.830
Why?
Lipoproteins
3
2011
80
0.830
Why?
Endothelium, Vascular
3
2011
151
0.790
Why?
Bacteremia
3
2011
88
0.760
Why?
Female
42
2022
27268
0.720
Why?
Severity of Illness Index
6
2018
1211
0.710
Why?
Visually Impaired Persons
1
2019
14
0.700
Why?
Antigens, Bacterial
2
2010
196
0.670
Why?
Central Nervous System Bacterial Infections
2
2010
3
0.660
Why?
Male
38
2022
23874
0.650
Why?
Adult
27
2019
13712
0.640
Why?
Middle Aged
26
2022
13864
0.640
Why?
Recovery of Function
1
2019
201
0.640
Why?
Humans
52
2022
52486
0.630
Why?
Treatment Outcome
8
2019
4171
0.600
Why?
Macaca mulatta
5
2005
210
0.600
Why?
Antibodies, Monoclonal, Humanized
3
2013
183
0.600
Why?
Gadolinium DTPA
3
2020
68
0.580
Why?
Apoptosis
4
2011
962
0.560
Why?
Inflammation
4
2017
1022
0.550
Why?
Exercise Test
2
2013
177
0.540
Why?
Benchmarking
1
2016
132
0.540
Why?
Blood-Brain Barrier
6
2017
72
0.530
Why?
Glatiramer Acetate
5
2016
7
0.510
Why?
Muscle, Skeletal
4
2022
608
0.510
Why?
Mice
16
2019
9521
0.490
Why?
Double-Blind Method
4
2019
546
0.490
Why?
Young Adult
10
2019
3794
0.470
Why?
Oligodendroglia
1
2013
30
0.470
Why?
Interferon-beta
5
2013
78
0.460
Why?
Animals
22
2019
18199
0.460
Why?
Patient Outcome Assessment
1
2013
49
0.450
Why?
Central Nervous System Diseases
1
2013
47
0.450
Why?
Self Report
1
2015
334
0.450
Why?
Contrast Media
4
2020
334
0.440
Why?
Simvastatin
1
2012
27
0.430
Why?
Chemokines, CXC
3
2007
25
0.430
Why?
Anti-Bacterial Agents
2
2016
615
0.420
Why?
Interferon beta-1b
4
2016
5
0.420
Why?
Encephalitis
1
2012
28
0.410
Why?
Mice, SCID
6
2009
493
0.410
Why?
Microcirculation
2
2008
44
0.400
Why?
Longitudinal Studies
7
2017
1070
0.380
Why?
Time Factors
9
2018
3219
0.370
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2012
207
0.370
Why?
Antibodies, Bacterial
6
2008
180
0.370
Why?
Spirochaetales Infections
1
2010
1
0.370
Why?
B-Lymphocytes
3
2009
526
0.370
Why?
Adolescent
9
2019
5369
0.360
Why?
Image Processing, Computer-Assisted
7
2020
568
0.360
Why?
Acute Disease
4
2019
616
0.350
Why?
Neuropsychological Tests
5
2014
301
0.340
Why?
Natalizumab
4
2018
10
0.340
Why?
Neurons
2
2013
789
0.330
Why?
Evoked Potentials, Visual
2
2018
9
0.320
Why?
Myocarditis
2
2005
27
0.310
Why?
Reproducibility of Results
7
2022
1365
0.310
Why?
Vestibular Diseases
1
2007
8
0.300
Why?
Gadolinium
4
2017
55
0.300
Why?
Cognition Disorders
3
2014
209
0.300
Why?
Cross-Sectional Studies
3
2022
2257
0.300
Why?
Peptides
4
2012
514
0.280
Why?
Surveys and Questionnaires
4
2019
2341
0.280
Why?
Root Canal Therapy
2
2017
3
0.280
Why?
Radiography, Dental, Digital
2
2017
3
0.280
Why?
Reverse Transcriptase Polymerase Chain Reaction
5
2008
491
0.270
Why?
Disease Models, Animal
4
2004
1828
0.270
Why?
Cerebrovascular Circulation
1
2006
129
0.270
Why?
T-Lymphocytes
2
2007
892
0.260
Why?
Cone-Beam Computed Tomography
2
2017
60
0.260
Why?
Borrelia burgdorferi Group
1
2004
27
0.250
Why?
Mice, Knockout
4
2011
1920
0.240
Why?
Heart Diseases
1
2005
180
0.230
Why?
Leukoencephalopathy, Progressive Multifocal
2
2013
17
0.230
Why?
Spinal Cord
1
2004
141
0.230
Why?
Homeodomain Proteins
2
2020
234
0.230
Why?
Quality of Life
4
2019
827
0.230
Why?
Adipose Tissue
2
2022
287
0.220
Why?
Serotyping
3
2007
46
0.220
Why?
Polymerase Chain Reaction
3
2009
459
0.220
Why?
Social Communication Disorder
1
2022
2
0.210
Why?
Placebos
2
2012
70
0.210
Why?
Fragile X Syndrome
1
2022
22
0.200
Why?
Cerebral Cortex
2
2017
224
0.200
Why?
Cyclopropanes
1
2021
35
0.200
Why?
Phenotype
1
2004
979
0.200
Why?
Cerebellar Nuclei
1
2020
4
0.200
Why?
Pyridines
1
2021
82
0.190
Why?
Gray Matter
1
2020
20
0.190
Why?
Cluster Analysis
2
2012
241
0.190
Why?
Tooth Root
2
2017
2
0.190
Why?
Retrospective Studies
6
2020
5111
0.190
Why?
Immunocompromised Host
3
2006
85
0.190
Why?
Myocardium
3
2006
192
0.190
Why?
Bites and Stings
3
2004
10
0.190
Why?
Chemokines
2
2013
89
0.180
Why?
Electroencephalography
2
2019
109
0.180
Why?
p38 Mitogen-Activated Protein Kinases
1
2020
109
0.180
Why?
White Matter
2
2019
97
0.180
Why?
Evoked Potentials, Somatosensory
1
2019
5
0.180
Why?
Evoked Potentials, Auditory
1
2019
9
0.180
Why?
DNA Primers
2
2010
281
0.180
Why?
Ixodes
3
2004
30
0.180
Why?
Biomarkers
2
2022
1038
0.180
Why?
Sickness Impact Profile
1
2019
31
0.180
Why?
Clinical Trials as Topic
2
2013
369
0.170
Why?
Statistics, Nonparametric
2
2012
184
0.170
Why?
Encephalomyelitis, Autoimmune, Experimental
1
2019
56
0.170
Why?
Immunosuppressive Agents
2
2012
263
0.170
Why?
Infusions, Intravenous
1
2019
154
0.170
Why?
Retinal Ganglion Cells
1
2018
18
0.170
Why?
Mice, Inbred C57BL
4
2019
2938
0.170
Why?
Optic Nerve
1
2018
25
0.170
Why?
Secondary Prevention
1
2019
137
0.170
Why?
Antibodies
2
2009
165
0.160
Why?
Autism Spectrum Disorder
1
2022
173
0.160
Why?
Hand
1
2018
55
0.160
Why?
Penicillin G
1
2016
6
0.150
Why?
Cefotaxime
1
2016
4
0.150
Why?
Amoxicillin
1
2016
7
0.150
Why?
PubMed
1
2017
17
0.150
Why?
Ceftriaxone
1
2016
17
0.150
Why?
Doxycycline
1
2016
35
0.150
Why?
International Cooperation
1
2017
82
0.150
Why?
Predictive Value of Tests
3
2013
845
0.140
Why?
Tomography, Optical Coherence
1
2018
168
0.140
Why?
Enzyme-Linked Immunosorbent Assay
2
2008
433
0.140
Why?
Upper Extremity
1
2016
45
0.140
Why?
Mice, Inbred BALB C
2
2009
837
0.140
Why?
Myocytes, Cardiac
2
2006
69
0.140
Why?
Hypophosphatemia
1
2015
5
0.130
Why?
Psychometrics
2
2014
332
0.130
Why?
DNA, Bacterial
2
2006
207
0.130
Why?
Activities of Daily Living
2
2014
281
0.130
Why?
Aged
6
2022
11411
0.130
Why?
Demography
1
2015
167
0.130
Why?
Endothelial Growth Factors
1
2014
16
0.130
Why?
Synovial Membrane
1
2014
18
0.130
Why?
Brain Injuries
1
2016
122
0.130
Why?
RNA, Bacterial
2
2004
61
0.120
Why?
Immunohistochemistry
3
2005
809
0.120
Why?
Heart
2
2007
235
0.120
Why?
Gait Disorders, Neurologic
1
2013
14
0.120
Why?
Autoantibodies
1
2014
154
0.120
Why?
Randomized Controlled Trials as Topic
1
2016
546
0.120
Why?
Radiography, Bitewing
1
2013
1
0.120
Why?
Dental Pulp Cavity
1
2013
2
0.120
Why?
Disabled Persons
1
2016
189
0.120
Why?
Interferon beta-1a
1
2013
9
0.110
Why?
Dexamethasone
2
2004
147
0.110
Why?
Neuroimaging
1
2013
90
0.110
Why?
Anti-Inflammatory Agents
2
2004
126
0.110
Why?
Follow-Up Studies
3
2013
1966
0.110
Why?
Employment
1
2013
128
0.110
Why?
Cell Survival
1
2013
514
0.100
Why?
Remission Induction
1
2011
127
0.100
Why?
Cell Line
3
2020
1934
0.100
Why?
fas Receptor
1
2011
55
0.100
Why?
Caspase 3
1
2011
96
0.100
Why?
Drug Administration Schedule
2
2015
248
0.100
Why?
Mice, Inbred Strains
1
2010
168
0.090
Why?
Drug Tolerance
1
2009
27
0.090
Why?
Neurologic Examination
1
2009
42
0.090
Why?
Molecular Conformation
1
2009
129
0.090
Why?
Diffusion Magnetic Resonance Imaging
1
2010
119
0.090
Why?
Tissue Distribution
1
2009
236
0.090
Why?
Observer Variation
1
2009
178
0.090
Why?
Prospective Studies
2
2013
2688
0.090
Why?
In Situ Nick-End Labeling
1
2008
39
0.080
Why?
Structure-Activity Relationship
1
2009
345
0.080
Why?
Phylogeny
1
2009
303
0.080
Why?
Coloring Agents
1
2008
50
0.080
Why?
Cognition
1
2012
422
0.080
Why?
Base Sequence
1
2010
1240
0.080
Why?
Interferon Type I
1
2009
165
0.080
Why?
Sensitivity and Specificity
1
2010
984
0.080
Why?
Aging
1
2013
696
0.080
Why?
Recombinant Proteins
1
2009
651
0.080
Why?
Arthritis
1
2007
42
0.070
Why?
Interleukin-6
1
2008
282
0.070
Why?
Hemorrhage
1
2008
241
0.070
Why?
Killer Cells, Natural
1
2008
211
0.070
Why?
Spleen
1
2008
456
0.070
Why?
Primates
1
2006
39
0.070
Why?
Immunoglobulins
1
2006
75
0.070
Why?
Antibody Formation
1
2006
106
0.070
Why?
Interferon-gamma
1
2008
512
0.070
Why?
Survival Rate
1
2008
666
0.070
Why?
Complement Activation
1
2006
52
0.070
Why?
Gene Expression Regulation, Bacterial
1
2007
116
0.070
Why?
Cells, Cultured
1
2010
2023
0.070
Why?
Oligonucleotide Array Sequence Analysis
1
2007
270
0.070
Why?
Down-Regulation
1
2007
282
0.070
Why?
Tumor Necrosis Factor-alpha
1
2008
552
0.070
Why?
Caspases
1
2006
153
0.070
Why?
Germinal Center
1
2005
34
0.070
Why?
Nervous System
1
2005
68
0.060
Why?
Safety
1
2005
124
0.060
Why?
Brain Infarction
1
2004
16
0.060
Why?
Cytokines
1
2008
852
0.060
Why?
Mice, Inbred C3H
1
2004
161
0.060
Why?
Complement C1q
1
2004
7
0.060
Why?
Fluorescent Antibody Technique, Indirect
1
2004
35
0.060
Why?
Leukocytes, Mononuclear
1
2005
229
0.060
Why?
Adjuvants, Immunologic
1
2005
208
0.060
Why?
Aorta
1
2004
93
0.060
Why?
Immunoenzyme Techniques
1
2004
104
0.060
Why?
Needles
1
2003
56
0.060
Why?
Signal Transduction
1
2013
2721
0.060
Why?
HIV Infections
1
2010
847
0.060
Why?
Genotype
1
2004
573
0.050
Why?
DNA-Binding Proteins
1
2008
1047
0.050
Why?
Multicenter Studies as Topic
1
2022
94
0.050
Why?
Child
3
2022
3965
0.050
Why?
Research Design
2
2018
540
0.050
Why?
RNA, Messenger
1
2007
1390
0.050
Why?
Immunity, Innate
1
2007
719
0.050
Why?
Area Under Curve
1
2021
111
0.050
Why?
Macrophages
1
2006
934
0.050
Why?
Muscle Cells
1
2020
25
0.050
Why?
Feasibility Studies
1
2022
461
0.050
Why?
Administration, Oral
1
2021
310
0.050
Why?
Cohort Studies
2
2017
2164
0.050
Why?
Myelin Sheath
1
2019
35
0.040
Why?
Linear Models
1
2020
413
0.040
Why?
Nerve Fibers
1
2018
21
0.040
Why?
Visual Fields
1
2018
23
0.040
Why?
Cell Death
1
2020
256
0.040
Why?
Visual Perception
1
2018
41
0.040
Why?
Photic Stimulation
1
2018
88
0.040
Why?
Software
1
2020
335
0.040
Why?
Communication
1
2022
481
0.040
Why?
Child, Preschool
1
2022
1707
0.040
Why?
Image Enhancement
1
2017
165
0.030
Why?
Prognosis
1
2018
1284
0.030
Why?
World Health Organization
1
2014
27
0.030
Why?
Imaging, Three-Dimensional
1
2016
238
0.030
Why?
Phosphates
1
2015
83
0.030
Why?
Space Perception
1
2014
19
0.030
Why?
Acoustic Stimulation
1
2014
46
0.030
Why?
Treatment Failure
1
2014
174
0.030
Why?
Demyelinating Diseases
1
2013
13
0.030
Why?
Immune Reconstitution Inflammatory Syndrome
1
2013
14
0.030
Why?
Calcium Sulfate
1
2013
1
0.030
Why?
Dental Restoration, Temporary
1
2013
1
0.030
Why?
Periapical Diseases
1
2013
1
0.030
Why?
Root Canal Irrigants
1
2013
1
0.030
Why?
Root Canal Obturation
1
2013
1
0.030
Why?
Zinc Oxide-Eugenol Cement
1
2013
1
0.030
Why?
Rubber Dams
1
2013
1
0.030
Why?
Root Canal Preparation
1
2013
1
0.030
Why?
Zinc Sulfate
1
2013
1
0.030
Why?
Root Canal Filling Materials
1
2013
2
0.030
Why?
Dental Restoration, Permanent
1
2013
2
0.030
Why?
Methylmethacrylates
1
2013
2
0.030
Why?
Anatomic Variation
1
2013
5
0.030
Why?
Sodium Hypochlorite
1
2013
10
0.030
Why?
Early Diagnosis
1
2013
78
0.030
Why?
Dose-Response Relationship, Drug
1
2015
730
0.030
Why?
Gene Expression Regulation
1
2020
1484
0.030
Why?
Mobility Limitation
1
2013
52
0.030
Why?
Memory
1
2014
111
0.030
Why?
Statistics as Topic
1
2013
143
0.030
Why?
Product Surveillance, Postmarketing
1
2012
18
0.030
Why?
Microscopy
1
2013
71
0.030
Why?
New York
1
2012
109
0.030
Why?
Diagnosis, Differential
1
2013
766
0.020
Why?
Analysis of Variance
1
2012
540
0.020
Why?
Single-Blind Method
1
2009
116
0.020
Why?
Monitoring, Physiologic
1
2009
127
0.020
Why?
Necrosis
1
2004
124
0.020
Why?
Immunoglobulin G
1
2005
424
0.010
Why?
Flow Cytometry
1
2005
638
0.010
Why?
Aged, 80 and over
1
2004
4428
0.010
Why?
Risk Factors
1
2004
4426
0.010
Why?
Cadavid's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (299)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_